Muscle Mass Loss During Chemotherapy Predicts Decreased Survival in Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
J. Clin. Oncol 2016 Feb 22;[EPub Ahead of Print], S Blauwhoff-Buskermolen, KS Versteeg, MA de van der Schueren, NR den Braver, J Berkhof, JA Langius, HM VerheulFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.